Management of ST Depression in Leads V3, V4, V5

Initial Assessment and Diagnosis

• The American College of Cardiology and the American Heart Association recommend obtaining a 12-lead ECG within 10 minutes of first medical contact to facilitate early diagnosis and triage, with ST depression ≥0.5 mm in leads V2 and V3 and ≥1.0 mm in all other leads consistent with myocardial ischemia 1, 2
• The American Heart Association recommends initiating continuous ECG monitoring immediately to detect life-threatening arrhythmias 2
• ST depression in leads V3-V5 may indicate non-ST elevation acute coronary syndrome (NSTE-ACS), possible posterior myocardial infarction, or potential left main or severe multivessel coronary artery disease 3, 4, 5, 6

Immediate Management

• The American College of Cardiology recommends administering aspirin 162-325 mg immediately, and adding clopidogrel to aspirin, as well as administering low molecular weight heparin or unfractionated heparin, and providing beta-blockers in the absence of contraindications 4
• The American Heart Association recommends administering oral or intravenous nitrates for persistent or recurrent chest pain, and obtaining serial cardiac biomarkers to detect myocardial damage 4, 1, 2

Risk Stratification

• The American College of Cardiology recommends classifying patients as high-risk if they present with recurrent ischemia, elevated cardiac troponin levels, hemodynamic instability, or major arrhythmias 4, 1
• Elevated cardiac troponin levels are associated with a higher risk of myocardial damage and poor outcomes 1, 4

Invasive Management Strategy

• The American College of Cardiology recommends that high-risk patients undergo coronary angiography as soon as possible, ideally within 24-48 hours, and that patients with severe ongoing ischemia, major arrhythmias, or hemodynamic instability undergo immediate angiography (within the first hour) 4

Special Considerations

• The American Heart Association recommends considering posterior MI if ST depression is maximal in leads V1-V3 with positive T waves, and obtaining additional posterior leads (V7-V9) where ST elevation ≥0.05 mV confirms posterior MI 5, 6, 7

Monitoring and Follow-up

• The American College of Cardiology recommends continuing continuous ECG monitoring for arrhythmias for at least 24 hours, performing echocardiography to assess left ventricular function, and considering stress testing or other non-invasive testing if coronary angiography is not performed and the diagnosis remains uncertain 3, 4

Long-term Management

• The American College of Cardiology recommends continuing dual antiplatelet therapy (DAPT) for up to 1 year in patients who undergo PCI, implementing secondary prevention measures including statins, ACE inhibitors, and lifestyle modifications, and enrolling patients in cardiac rehabilitation programs 4

Pitfalls to Avoid

• The American Heart Association recommends not administering fibrinolytic therapy to patients with isolated ST depression, as it may increase mortality, and not dismissing ST depression as non-specific changes, especially when present in multiple contiguous leads 5, 1, 2

Acute Management of Sinus Rhythm with ST Depression Indicative of Sub‑Endocardial Ischemia

Immediate Diagnostic Actions

• Record posterior leads V7‑V9 immediately; ST‑elevation ≥ 0.05 mV (≥ 0.1 mV in men > 40 y) on these leads identifies a posterior STEMI that requires emergent primary PCI with door‑to‑balloon < 90 min, equivalent to an anterior STEMI. – European Society of Cardiology (ESC) guideline 8
• Obtain continuous 12‑lead ECG monitoring at presentation and maintain it until NSTEMI is excluded; admission to a monitored unit is recommended. – ESC guideline 9

Anticoagulation Strategy

• In addition to unfractionated heparin, low‑molecular‑weight heparin or fondaparinux may be used according to institutional protocol for NSTE‑ACS. – ESC guideline 10

Risk Stratification & Timing of Invasive Coronary Angiography

Immediate Angiography (< 2 h) – Class I, LOE A

• Hemodynamic instability or cardiogenic shock. – ESC guideline 10
• Recurrent or ongoing chest pain despite optimal medical therapy. – ESC guideline 8
• Life‑threatening ventricular arrhythmias (VT/VF). – ESC guideline 10
• Widespread ST‑depression (≥ 8 leads) with concurrent ST‑elevation in aVR, suggesting left‑main or severe multivessel disease. – ESC guideline 8

Early Angiography (within 24 h) – Class I, LOE A

• Elevated high‑sensitivity cardiac troponin on presentation. – ESC guideline 9
• Dynamic ST‑segment or T‑wave changes on serial ECGs. – ESC guideline 9
• GRACE risk‑score > 140. – ESC guideline 9

Additional Recommendations

• Do not postpone invasive angiography when ongoing ischemia persists despite medical therapy; this is an absolute indication for emergency catheterisation even without diagnostic ST‑elevation. – ESC guideline 8
• Always obtain posterior leads (V7‑V9) when isolated anterior ST‑depression is present, because the pattern may mask a posterior STEMI. – ESC guideline 8

Serial Biomarker Protocol

• Draw high‑sensitivity cardiac troponin at presentation (0 h) and repeat at 1 h, applying the ESC 0‑hour/1‑hour algorithm for rapid rule‑out or rule‑in of NSTEMI. – ESC guideline 9
• If hs‑cTn is unavailable, employ a validated 0‑hour/3‑hour protocol. – ESC guideline 9

Monitoring and Imaging

Continuous Monitoring

• Maintain continuous ECG monitoring for at least 24 h (longer if high arrhythmic risk) after stabilisation. – ESC guideline [9][11]

Echocardiography

• Perform bedside transthoracic echocardiography to assess regional wall‑motion abnormalities, left‑ventricular function, and to exclude alternative diagnoses (e.g., pericardial effusion, aortic dissection, pulmonary embolism). – ESC guideline [9][11]

Post‑Stabilisation Therapy

• Initiate an ACE‑inhibitor within 24 h in patients with left‑ventricular ejection fraction ≤ 40 %. – ESC guideline 10
• Perform formal GRACE‑score risk stratification to guide long‑term management decisions. – ESC guideline 9

All statements are based on ESC guideline recommendations (Class I, Level A evidence where specified).